Ashland has opened a new pharmaceutical excipient facility in Nanjing, China. Demand for polymer excipients, the substances formulated alongside the active ingredients of medications, is rising in China as the country’s pharmaceutical industry moves to modernize oral drug manufacturing and comply with new quality standards set forth in the 2015 edition of the Chinese Pharmacopoeia. “Opening a world-class excipient facility in Nanjing is a testament to our willingness to partner with industry ...